Drugs like Ozempic now make up 5% of prescriptions in the US

Anecdotes like this are everywhere: people taking diet pills find hunger doesn’t exist The only desire that seems to stop.

Eli Lilly CEO David Ricks said his company will pursue these clues next year to test whether its GLP-1 drug Tezepatide (The drug for diabetes is called Mounjaro, and the drug for weight loss is called Zepbound.) It can help break addictions to alcohol, nicotine and “other things we don’t think about.” [as being] Related to weight.

exist His comments in DecemberRicks says these drugs may be “anti-hedonic” – meaning they counteract our hedonistic pursuit of pleasure, whether it comes from food, Alcoholor drugs. a study A dig into digital health records this year found that people addicted to opioids are about half as likely to overdose.

sleep apnea

The idea goes back a long way, including a 2015 case study of a 260-pound man with diabetes and sleep apnea. As he continued taking liraglutide, doctors noticed an improvement in his sleep.

People with sleep apnea experience gasping for breath at night, which is annoying and can lead to health problems over time. This year, Eli Lilly and Company new england journal of medicine its medicine Tezepatide found that it reduced breathing interruptions by 50% in overweight patients with sleep apnea.

longevity

This year, the U.S. Food and Drug Administration Wegovy approved as cardiovascular drugpreviously researchers showed these drugs could reduce heart disease and strokes in overweight people.

But that’s not all. The study involving 17,000 people found that the drug reduced the overall chance of someone dying from any cause (called “all-cause mortality”) by 19%.

Now that’s causing concern among aging researchers. This year They list Wegovy and similar drugs as one of the top four candidates for a universal life-extending drug.